On July 5th, Gelunhui reported that Zhejiang Xianju Pharmaceutical (002332.SZ) recently received the "Drug Registration Certificate" (Certificate No. 2024S01558) approved and issued by the National Medical Products Administration for its estradiol valerate tablets and the tablets have been approved for registration.
The estradiol valerate tablets (1mg) applied for by Zhejiang Xianju Pharmaceutical Co., Ltd. in this application are consistent with the specifications of the original drug, Bu Jiale, which was granted import registration permission in China in 1997 with a specification of 1mg. The application is classified as a chemical drug under Category 4.